caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881701944

Kevin HallMD

Gynecological OncologySan Antonio, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
68
Beneficiaries
—
Total drug cost
$234K
Distinct drugs
4
Brand share
30.9%
Top prescribed drugs
Olaparib21 claims
Clobetasol Propionate17 claims
Estradiol17 claims
Fluconazole13 claims
REFERRAL NETWORK

Where Kevin Hall's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Philip Valente
Pathology · San Antonio, TX
2876
Maria Luisa Policarpio-Nicolas
Pathology · Cleveland, OH
1644
Edward Kost
Gynecological Oncology · San Antonio, TX
1475
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$244
Payment records
3
By payment type
Food and Beverage$244
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
150
Unique beneficiaries
—
Total services
217
Distinct HCPCS
5
Medicare payment
$15K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 81 Gynecological Oncology providers in TX — below median (cohort median 361).